Merging intensive psychotherapy with a chaste type of the party drug ecstasy is harmless and can assist revival in individuals with PTSD (post-traumatic stress disorder), as per the results of a research in military veterans. The researchers who executed the study—a small trial consisting of merely 26 individuals—stated its outcomes proposed that with close psychological and medical observation, giving MDMA to patients with PTSD “can augment the advantages of psychotherapy.”
The research is among the numerous mid-stage assessments investigating the prospective for 3,4-methylenedioxymethamphetamine, or MDMA—the key active constituent of ecstasy—to be utilized together with psychotherapies in individuals suffering PTSD and combat trauma.
Last year, the US drug authority assigned MDMA-aided psychotherapy for PTSD an “innovative therapy”—implying it can be speeded up for review and possible consent. This most recent study was not outlined to assess the efficacy of the treatment, but to evaluate the safety.
The study volunteers—firefighters, one police officer, and service personnel—were arbitrarily allocated to obtain either 125 mg, 75 mg, or 30 mg MDMA doses in addition to psychotherapy, and their side-effects and symptoms were monitored.
The therapy had few adverse effects—comprising insomnia, anxiety, and few transient boosts in suicidal feelings—but was established to be on the whole safe and exhibited promise in easing PTSD symptoms, as said by the researchers. They stated a larger efficacy study is now required to evaluate the complete potential of the MDMA therapy.
Also, they cautioned that this study was carried out in a highly controlled setting utilizing “medical grade” MDMA, thus, PTSD patients should not attempt this on owing to the risks linked to street ecstasy.
In another report, clinical trials wherein MDMA would be attempted as a therapy for alcoholism have been started off and will be directed by the Imperial College London.